Lack of detectable platelet autoantibodies is correlated with nonresponsiveness to rituximab treatment in ITP patients

Leendert Porcelijn, Elly Huiskes, Martin Schipperus, Bronno van der Holt, Masja de Haas and Jaap Jan Zwaginga for the Dutch HOVON 64 Study Group

You do not have access to the full text of this article, the first page of the PDF of this article appears below.

PDF extract preview